Clinical factors associated with hypomagnesemia among patients with cardiac conditions: cross-sectional study
Abstract
Background. Serum magnesium levels are usually measured and corrected, if warranted, among patients with cardiac diseases.
Objective. To determine the rate of and clinical factors associated with hypomagnesemia among patients with cardiac conditions.
Design. Cross-sectional study.
Setting. Davao Regional Medical Center (DRMC) in Tagum City, Philippines, from January 2014 to January 2016.
Participants. 59 males and 53 females with cardiac diagnoses and serum magnesium level determination results.
Main outcome measures. Rate of hypomagnesemia, odds ratios (95% CI) of having hypomagnesemia for selected clinical factors.
Main results. The mean age of the patients was 60.72 ± 16.73 years. The mean serum magnesium level was 0.75 ± 0.23 mmol/L, and 47/112 (41.96%) had hypomagnesemia (serum magnesium <0.7 mmol/L). Unadjusted prevalence odds ratios (POR) for having hypomagnesemia were significantly high for chronic obstructive pulmonary disease (COPD) comorbidity (POR=5.50; 95% CI 1.09 to 27.76; p=0.0392), stroke comorbidity (POR=2.78; 95% CI 1.15 to 6.71; p=0.0227), taking diuretic medications (POR=4.66; 95% CI 1.38 to 15.71; p=0.0132), and having atrial fibrillation during the admission (POR=2.26; 95% CI 1.04 to 4.91; p=0.0394).
Conclusion. In this study, 41.96% of the patients had hypomagnesemia. COPD and stroke comorbidities, diuretic therapy, and atrial fibrillation among patients with cardiac conditions were all significantly associated with hypomagnesemia.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International License that allows others to share the work for non-commercial purposes with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional, non-commercial contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors grant the journal permission to rewrite, edit, modify, store and/or publish the submission in any medium or format a version or abstract forming part thereof, all associated supplemental materials, and subsequent errata, if necessary, in a publicly available publication or database.
- Authors warrant that the submission is original with the authors and does not infringe or transfer any copyright or violate any other right of any third parties.